IDNA vs. LGHT ETF Comparison
Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to Langar Global HealthTech ETF (LGHT)
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Grade (RS Rating)
Last Trade
$24.50
Average Daily Volume
22,642
34
LGHT
Langar Global HealthTech ETF
LGHT Description
LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.Grade (RS Rating)
Last Trade
$10.28
Average Daily Volume
686
31
Performance
| Period | IDNA | LGHT |
|---|---|---|
| 30 Days | 0.04% | -3.23% |
| 60 Days | -1.84% | -3.02% |
| 90 Days | 3.10% | 2.70% |
| 12 Months | 33.25% |
1 Overlapping Holdings
| Symbol | Grade | Weight in IDNA | Weight in LGHT | Overlap | |
|---|---|---|---|---|---|
| MRNA | F | 1.43% | 2.38% | 1.43% |
IDNA Overweight 33 Positions Relative to LGHT
| Symbol | Grade | Weight | |
|---|---|---|---|
| GILD | A | 5.61% | |
| BGNE | C | 5.52% | |
| EXEL | A | 5.2% | |
| RVMD | A | 4.7% | |
| INCY | A | 4.49% | |
| SRPT | D | 4.34% | |
| ACLX | B | 3.85% | |
| REGN | F | 3.8% | |
| MRK | F | 3.25% | |
| IOVA | B | 2.72% | |
| TWST | F | 2.58% | |
| GERN | C | 2.32% | |
| LGND | A | 2.24% | |
| SWTX | D | 2.2% | |
| BEAM | F | 1.89% | |
| BCRX | A | 1.8% | |
| NRIX | B | 1.7% | |
| DVAX | A | 1.59% | |
| NVAX | F | 1.48% | |
| BPMC | C | 1.29% | |
| CRSP | C | 0.98% | |
| IBRX | B | 0.94% | |
| RCUS | F | 0.89% | |
| VIR | B | 0.76% | |
| ARCT | F | 0.53% | |
| OABI | D | 0.41% | |
| FDMT | F | 0.4% | |
| NTLA | F | 0.39% | |
| QURE | B | 0.36% | |
| DNA | D | 0.33% | |
| XNCR | A | 0.32% | |
| EDIT | F | 0.3% | |
| MGNX | C | 0.23% |
IDNA Underweight 30 Positions Relative to LGHT
| Symbol | Grade | Weight | |
|---|---|---|---|
| ISRG | B | -14.59% | |
| GEHC | D | -9.12% | |
| RMD | A | -7.12% | |
| IQV | F | -6.5% | |
| DXCM | C | -5.26% | |
| PHG | D | -5.01% | |
| VEEV | B | -4.73% | |
| PODD | A | -4.72% | |
| BNTX | B | -3.9% | |
| ZBH | C | -3.55% | |
| ALGN | F | -2.67% | |
| MASI | A | -2.24% | |
| DOCS | A | -1.67% | |
| PRCT | A | -1.35% | |
| TNDM | F | -0.6% | |
| ALKS | F | -0.6% | |
| OMCL | B | -0.45% | |
| EVH | D | -0.41% | |
| IRTC | C | -0.39% | |
| PRVA | B | -0.38% | |
| LFST | C | -0.3% | |
| TDOC | C | -0.29% | |
| PGNY | F | -0.28% | |
| GDRX | F | -0.27% | |
| ALHC | A | -0.2% | |
| SDGR | F | -0.19% | |
| PHR | F | -0.15% | |
| ACCD | F | -0.06% | |
| TBRG | A | -0.03% | |
| MODV | F | -0.03% |
IDNA: Top Represented Industries & Keywords
LGHT: Top Represented Industries & Keywords
Compare ETFs
